 Impaired microbiome diversity and composition can develop into a potent etiological agent of disease and increase susceptibility to infection . Given this interventions targeting the microbiome have developed rapidly with healthy donor feces being a

@highlight Fecal transplants despite associated risks are now a widely accepted therapeutic.
@highlight Bacterial species and functions consistently associated with efficacy have been identified.
@highlight Recent research indicates fungi and viruses are associated with therapy outcomes.
@highlight Limited data exists on the influence of host diet and genetics on therapy efficacy.
@highlight Modified fecal communities and lab based microbial therapies have been tested.
